Filter by Type
10 Key Strategies for Selling to IDNs and GPOs
After 35+ years in the industry, John Pritchard and Ken Murawski know what works when it comes to selling to Integrated Delivery Networks and Group Purchasing Organizations. In this webinar, tap into their collective knowledge and learn how you too…
Current industry trends: Selling in a changed market
In January 2020, we presented on healthcare trends because we feel confident that the best way to sell is to understand the key challenges of your target audience. Due to COVID-19, those key challenges have shifted. In this updated webinar, attendees…
Exploring Rare Disease through a Data-Driven Lens
While the complexities for rare disease treatment are numerous, the last few years have shown major strides towards meaningful progress. In honor of Rare Disease Day 2021, join us as we explore hurdles and opportunities for biotech and pharmaceutical…
How pharma firms use our solutions
The process of bringing a new drug or therapy to market poses a unique set of challenges. A data-driven approach can fuel your team’s early stage strategy during phase III clinical trials, registration/PDUFA set, planning sales territories, and…
A panel discussion on med device sales strategies
Anyone who markets, sells, or buys medical devices should tune in to this expert panel. Watch this panel if you want to hear your sales and marketing peers share their own best practices, gain insights into your target buyer, or leverage a clinician…
Proven tactics for working with IDNs
Vendors are facing more challenges and barriers than ever before. With meaningful access to key customers shrinking and an increase in bundling by GPOs and large manufacturers, relational strategy is becoming increasingly important. In our next…
Codifying the patient journey
A playbook for selling to healthcare providers has some of the same chapters you’d see in any B2B sales playbook. Total addressable market defined? Territories built? Check, and check. The similarities go on.
Examining the COVID-driven rise of telehealth with claims
COVID-19 has served as the ultimate catalyst to telehealth and telemedicine; we’ve seen years of regulations around telehealth come undone to respond to the market need of virtual health options. As a result, over 41 million telehealth claims have…